share_log

HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target

HC Wainwright & Co. Reiterates Buy on Cyclo Therapeutics, Maintains $3 Price Target

HC Wainwright & Co.重申买入Cyclo Therapeutics,维持3美元的目标股价
Benzinga ·  05/31 06:17

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains $3 price target.

HC Wainwright & Co. 分析师Swayampakula Ramakanth重申Cyclo Therapeutics(纳斯达克股票代码:CYTH)的买入并维持3美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发